Representative before the EPO

Company dna stratagem ipm limited
no operation time available
3 offices
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 16 EP applications Stephen John Eves Evans has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 11, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12709382

COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

IPC classification:
A61K 39/39, A61K 39/295, A61K 39/13, A61K 39/095, A61K 39/00, A61K 33/42, A61K 33/08, A61K 33/06, A61K 31/66, A61K 31/4375
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Agent:
Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12781365

FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

IPC classification:
A61K 39/05
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13705791

PILUS PROTEINS AND COMPOSITIONS

IPC classification:
C07K 1/00
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15151845

Fermentation processes for cultivating streptococci and purification processes for obtaining CPS therefrom

IPC classification:
A61K 39/00, C12Q 3/00, C12P 19/04, C12N 1/20
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13766496

OUTER MEMBRANE VESICLES

IPC classification:
A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13802107

CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

IPC classification:
A61K 39/40, A61K 39/08, C12N 15/31, C07K 16/12, C07K 14/33, A61P 31/04
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13792601

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/09
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13795176

IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/13, A61K 39/09, A61K 39/08, A61K 39/05, A61K 39/02, A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
The patent has been granted
EP14167449

Polysaccharides produced by CPSC mutants

IPC classification:
A61K 39/09, C12P 19/04, C08B 37/00, C07K 14/315
Applicant:
Novartis AG
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION REFUSED
EP15193267

HYBRID POLYPEPTIDES INCLUDING MENINGOCOCCAL FHBP SEQUENCES

IPC classification:
C07K 14/22, A61K 39/095
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15707351

MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES

IPC classification:
C07K 14/095, C07K 14/22, A61K 39/095
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION REQUESTED
EP15720977

PURIFICATION OF SECRETED POLYSACCHARIDES FROM S. AGALACTIAE

IPC classification:
C07K 14/315, C08B 37/00, A61K 39/09, C12P 19/04
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15744610

CARRIER MOLECULE FOR ANTIGENS

IPC classification:
A61P 37/04, A61K 47/50
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION REQUESTED
EP15813399

PURIFICATION OF STREPTOCOCCAL CAPSULAR POLYSACCHARIDE

IPC classification:
A61K 39/09, C08B 37/00
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
Request for examination was made
EP16177013

IMMUNOGENIC COMPOSITIONS

IPC classification:
C12R 1/36, A61K 39/095, A61K 35/74, C12N 9/14, C12N 1/21
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
The application has been published
EP16734627

IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/09
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Stephen John Eves Evans, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature